Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Hematology|June 9, 2025
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationChihiro Kamoi, Toshiki Terao, Yui Kambara, et al.
Cytotherapy|January 23, 2025
Severe hypophosphatemia following idecabtagene vicleucel regardless of the severity of cytokine release syndromeKenta Hayashino, Wataru Kitamura, Nobuharu Fujii, et al.
International Journal of Hematology|September 8, 2021
Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantationTaiga Kuroi, Nobuharu Fujii, Koichi Ichimura, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 1, 2021
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collectionKeiko Fujii, Nobuharu Fujii, Takumi Kondo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 5, 2025
[Treatment outcomes of axicabtagene ciloleucel for relapsed/refractory diffuse large B-cell lymphoma: a retrospective analysis at a single institution]Wataru Kitamura, Nobuharu Fujii, Chihiro Kamoi, et al.
Transfusion|February 29, 2024
Collection efficiency and safety of large-volume leukapheresis for the manufacturing of tisagenlecleucelWataru Kitamura, Tomohiro Urata, Keiko Fujii, et al.
International Journal of Hematology|December 16, 2024
Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factorsKenta Hayashino, Toshiki Terao, Hisakazu Nishimori, et al.
International Journal of Hematology|June 13, 2025
A successful control of cardiac amyloidosis by idecabtagene vicleucel in a patient with relapsed and refractory multiple myeloma: a case report and literature reviewYayoi Ueda, Toshiki Terao, Nobuharu Fujii, et al.
Annals of Hematology|February 24, 2025
A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHDWataru Kitamura, Keiko Fujii, Mitsuru Tsuge, et al.
Laboratory Medicine|March 26, 2025
Markedly elevated serum level of presepsin in agranulocytosis with hematologic malignancy: A potential prognostic factor in a single-institution retrospective study after granulocyte transfusionTakuya Fukumi, Keiko Fujii, Wataru Kitamura, et al.
Pageof 4